AdaptHealth Corp.
AHCOHealthcareNASDAQMedical Devices · Last scanned May 30, 2026
Scan Results
Daily timeframeHeadquartered within the healthcare sector, AdaptHealth Corp. focuses on Medical Devices services and products. AdaptHealth Corp., together with its subsidiaries, distributes home medical equipment (HME), medical supplies, and home and related services in the United States. At a $1.38B market cap, AdaptHealth Corp. ranks as a small-cap company within healthcare. It operates through Sleep Health, Respiratory Health, Diabetes Health, and Wellness at Home segments.
Market Cap
$1.38B
Beta
1.57
P/E (TTM)
—
P/E (Fwd)
8.63
EPS (TTM)
$-0.59
EPS (Fwd)
$1.17
ROE
-4.9%
ROA
2.6%
Cash
$48.0M
Total Debt
$2.00B
Free CF
$267.9M
52W Change
15.8%
Annual Financials
Cash vs Debt
On the balance sheet, AHCO has $48.0M in cash with $2.00B in obligations. The ability to service this debt comfortably depends on continued operational cash generation. The company generates $267.9M in free cash flow annually, which funds everything from R&D to shareholder returns without needing external financing. Return on equity stands at -4.9%, which is negative for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. ROA of 2.6% is on the lower side, which is common in asset-heavy industries. Revenue has been relatively flat, moving from $2.97B (2022) to $3.24B (2025).
A beta of 1.57 means AHCO is more volatile than average. Investors should be prepared for wider price swings relative to broader indices. AdaptHealth Corp. carries a heavier debt load relative to its cash position, which introduces financial risk that investors should weigh. No single metric tells the full story. Reviewing AHCO's risk profile alongside its fundamentals and technical indicators provides a more complete picture.